Breast cancer cells in the laboratory that don’t respond to tamoxifen may be producing high amounts of cholesterol in order to provide a kind of shield against the drug, say researchers.
Breast cancer cells in the laboratory that don’t respond to tamoxifen may be producing high amounts of cholesterol in order to provide a kind of shield against the drug, say researchers.